Clinical study on the effect of Anning therapeutics combined with Bufei Decoction on the quality of life of patients with end-stage non-small cell lung cancer (NSCLC) (Qi deficiency syndrome)

INTERVENTION: Control group (hospice treatment group, simulant + hospice care):Bufei Tang granule simulant, 1 bag each time, twice a day, washed with warm water. Joint hospice care.;Test group (observation group, Bufei Decoction + hospice care):Bufei Decoction granules, 1 bag each time, twice a day, washed with warm water. Joint hospice care.; DZ01SY02 CONDITION: End stage non‐small cell lung cancer PRIMARY OUTCOME: EORTC QLQ‐C30;ECOG;CFS; INCLUSION CRITERIA: ? The diagnosis of advanced non‐small cell lung cancer (stage ? b‐ ?) is supported by cellular and pathological diagnosis. ? Those who meet the above diagnostic criteria of Chinese and Western medicine are patients with Qi deficiency syndrome. ? On the premise that the patient fully understands the condition, the estimated survival time can reach 3 months or more. ? The patient knows all the contents of hospice care, and the patient is too weak to receive anti‐cancer treatment, or the patient refuses to continue anti‐cancer treatment; ? No mental illness and consciousness disorder, can communicate normally; ? On the premise of full knowledge, the patients voluntarily participated in the study, agreed to follow‐up and were qualified. ? No treatment with traditional Chinese medicine within 3 months before treatment.